Sarissa Capital Management as of Dec. 31, 2024
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 8 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 39.1 | $126M | 7.3M | 17.35 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 22.5 | $73M | 16M | 4.43 | |
| Neurocrine Biosciences (NBIX) | 13.1 | $42M | 309k | 136.50 | |
| Cytokinetics Com New (CYTK) | 12.1 | $39M | 834k | 47.04 | |
| Gilead Sciences (GILD) | 7.5 | $24M | 262k | 92.37 | |
| Amarin Corp Spons Adr New | 3.7 | $12M | 25M | 0.48 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.7 | $5.6M | 63k | 89.46 | |
| Vor Biopharma | 0.2 | $686k | 618k | 1.11 |
